// App-Quantinova.ai

TCT-6 : Simultaneous Impact of Thrombotic and Bleeding Risks on Use of Novel P2Y12 inhibitors in Contemporary PCI: Results from a Large Single-Center Registry

Researchers

Presenter

  • Usman Baber

Principal Investigators

  • Roxana Mehran

  • Serdar Farhan

  • Annapoorna Kini

  • Melissa Aquino

  • Jason Kovacic

  • Joseph Sweeny

  • Pedro Moreno

  • Srushti Shah

  • Pooja Vijay

  • George Dangas

  • Nitin Barman

Medical Centers

  • CUMC, New York, New York, United States

  • NY-Mt Sinai Hospital, New Yrk, New York, United States

  • Cardiovascular Research Foundation, Zena and Michael A. Weiner Cardiovascular Institute at Mount Sinai School of Medicine, New York, New York, United States

  • Icahn School of Medicine at Mount Sinai, New York, New York, United States

  • Montefiore Medical Center, Medicine, New York, United States

  • Montefiore Medical Center, Medicine, New York, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Ticagrelor

  • Prasugrel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved